Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RLYBRallybio Corp

Nasdaq · CIK 0001739410
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts227

Identity from submissions API

NameRallybio Corp
CIK0001739410
TickersRLYB
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN851083789
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone203- 859-3820
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Rallybio Holdings, LLC (2018-05-07T04:00:00.000Z → 2021-06-07T04:00:00.000Z)
Business address
234 CHURCH STREET
SUITE 1020
NEW HAVEN
CT
06510
CT
Mailing address
234 CHURCH STREET
SUITE 1020
NEW HAVEN
CT
06510
CT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

314 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 425 425 0001193125-26-458630 001-40693 261547786 34 25499
2026-11-12 8-K 8-K 8.01 0001193125-26-458624 001-40693 261547771 34 147695 1 1
2026-11-10 425 425 0001193125-26-455769 001-40693 261541667 34 49341
2026-11-10 8-K 8-K 8.01,9.01 0001193125-26-455762 001-40693 261541596 34 179007 1 1
2026-11-06 425 425 0001193125-26-452121 001-40693 261533105 34 18301
2026-11-06 8-K 8-K 8.01 0001193125-26-452115 001-40693 261533093 34 138011 1 1
2026-11-05 4 4 0001193125-26-450103 14457
2026-11-05 4 4 0001193125-26-450102 7090
2026-11-04 8-K 8-K 5.02,5.07,8.01,9.01 0001193125-26-447550 001-40693 261523515 34 200340 1 1
2026-11-03 4 4 0001193125-26-445701 6922
2026-11-02 4 4 0001193125-26-443915 10538
2026-11-02 4 4 0001193125-26-443898 14199
2026-10-30 4 4 0001193125-26-441964 6853
2026-10-29 4 4 0001193125-26-438086 6846
2026-10-28 4 4 0001193125-26-436314 6257
2026-10-28 4 4 0001193125-26-436313 6823
2026-10-27 10-Q 10-Q 0001628280-26-067422 001-40693 261487396 34 6064952 1 1
2026-10-26 425 425 0001193125-26-432123 001-40693 261486533 34 31790
2026-10-26 8-K 8-K 8.01 0001193125-26-432114 001-40693 261486503 34 156085 1 1
2026-10-20 4 4 0001193125-26-426875 6804
2026-10-20 4 4 0001193125-26-426872 6851
2026-10-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003252 333-297483 261464242 33 1834
2026-10-15 424B3 424B3 0001193125-26-422924 333-297483 261463358 33 13049847
2026-10-14 S-4/A S-4/A NO. 4 0001193125-26-421809 333-297483 261460567 33 13170928
2026-10-14 4 4 0001193125-26-421747 14223
2026-10-13 4 4 0001193125-26-420562 6871
2026-10-08 4 4 0001193125-26-418051 6886
2026-10-05 S-4/A S-4/A NO. 3 0001193125-26-412774 333-297483 261438493 33 13235901
2026-10-01 4 4 0001193125-26-410885 6873
2026-09-28 4 4 0001193125-26-405753 10358
2026-09-18 4 4 0001193125-26-395755 6572
2026-09-16 S-4/A S-4/A NO. 2 0001193125-26-392246 333-297483 261382070 33 13259908
2026-09-09 8-K 8-K 5.02,9.01 0001193125-26-386511 001-40693 261368491 34 167183 1 1
2026-08-26 S-4/A S-4/A 0001193125-26-368568 333-297483 261323263 33 28283980 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097296 005-92742 261283084 34 11052
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003694 005-92742 261279720 34 9651
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003435 005-92742 261275845 34 13606
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002189 005-92742 261247384 34 11616
2026-08-06 10-Q 10-Q 0001628280-26-053880 001-40693 261246123 34 6055363 1 1
2026-08-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001390202-26-000012 005-92742 261238444 34 11255
2026-07-15 S-4 S-4 0001193125-26-304966 333-297483 261178113 33 30268499 1 1
2026-07-10 4 4 0001193125-26-300913 6600
2026-06-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-071013 005-92742 261069698 34 14622
2026-06-01 425 425 0001193125-26-249801 001-40693 261047299 34 16266076
2026-06-01 8-K 8-K 1.01,3.02,5.01,5.02,7.01,9.01 0001193125-26-249790 001-40693 261047288 34 16757593 1 1
2026-05-20 4 OWNERSHIP DOCUMENT 0001104659-26-064729 12110
2026-05-15 4 OWNERSHIP DOCUMENT 0001104659-26-062883 13276
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-002426 005-92742 26990056 34 31123
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062682 005-92742 26988817 34 10850
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002223 005-92742 26985295 34 10849
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225116 005-92742 26981925 34 126337
2026-05-13 4 OWNERSHIP DOCUMENT 0001104659-26-060513 13805
2026-05-13 10-Q 10-Q 0001628280-26-034580 001-40693 26973097 34 5314293 1 1
2026-05-06 4 OWNERSHIP DOCUMENT 0001104659-26-056540 12665
2026-05-06 3 OWNERSHIP DOCUMENT 0001104659-26-056538 6736
2026-05-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001674324-26-000004 005-92742 26949396 34 17674
2026-05-05 RW RW 0001193125-26-206462 333-294361 26943390 NE 8119
2026-05-04 8-K 8-K 1.02,9.01 0001193125-26-202601 001-40693 26934673 34 158845 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001390202-26-000007 005-92742 26911863 34 11534
2026-04-24 S-4/A S-4/A NO. 1 0001193125-26-177461 333-294361 26894930 33 10635423
2026-04-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000904454-26-000233 005-92742 26856894 34 9905
2026-03-31 8-K 8-K 5.02 0001628280-26-022385 001-40693 26821766 34 145423 1 1
2026-03-17 S-4 S-4 0001193125-26-108699 333-294361 26758206 33 23741223 1 1
2026-03-16 10-K 10-K 0001628280-26-018261 001-40693 26757951 34 9082287 1 1
2026-03-10 3 3 0001193125-26-099788 5719
2026-03-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000665 005-92742 26728990 34 11270
2026-03-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000664 005-92742 26728976 34 11225
2026-03-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001999371-26-004957 005-92742 26715148 34 21915
2026-03-02 425 425 0001193125-26-084452 001-40693 26703966 34 5918244
2026-03-02 8-K 8-K 1.01,3.02,5.01,5.02,7.01,9.01 0001193125-26-084444 001-40693 26703918 34 6396984 1 1
2026-02-27 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001674324-26-000002 005-92742 26701061 34 18250
2026-02-23 4 FORM 4 0001739410-26-000022 6228
2026-02-20 4 FORM 4 0001628280-26-010334 5607
2026-02-20 4 FORM 4 0001739410-26-000015 5601
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-26-000885 005-92742 26642029 34 34920
2026-01-29 8-K 8-K 5.03,5.07,9.01 0001739410-26-000010 001-40693 26579290 34 174341 1 1
2026-01-02 DEF 14A DEF 14A 0001140361-26-000191 001-40693 26502391 34 1718301
2025-12-23 PRE 14A PRE 14A 0001140361-25-046536 001-40693 251600416 34 1718345
2025-11-06 10-Q 10-Q 0001739410-25-000132 001-40693 251456297 34 6033954 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001739410-25-000131 001-40693 251456287 34 235418 1 1
2025-08-29 8-K 8-K 3.01,9.01 0001193125-25-192749 001-40693 251280815 34 144074 1 1
2025-08-07 10-Q 10-Q 0001739410-25-000112 001-40693 251191807 34 5670097 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001739410-25-000108 001-40693 251191751 34 241445 1 1
2025-07-08 8-K 8-K 1.01,2.01,8.01,9.01 0001739410-25-000100 001-40693 251109554 34 173752 1 1
2025-06-27 8-K 8-K 5.02,9.01 0001739410-25-000093 001-40693 251086385 34 302600 1 1
2025-05-16 8-K 8-K 5.07 0001739410-25-000089 001-40693 25957048 34 159872 1 1
2025-05-15 4 FORM 4 0001739410-25-000087 5414
2025-05-15 4 FORM 4 0001739410-25-000086 5405
2025-05-15 4 FORM 4 0001739410-25-000085 5426
2025-05-15 4 FORM 4 0001739410-25-000084 5437
2025-05-15 4 FORM 4 0001739410-25-000083 5450
2025-05-15 4 FORM 4 0001739410-25-000082 5388
2025-05-15 4 FORM 4 0001739410-25-000081 5391
2025-05-15 4 FORM 4 0001739410-25-000080 5428
2025-05-09 S-8 S-8 0001739410-25-000069 333-287143 25930382 33 88790
2025-05-08 10-Q 10-Q 0001739410-25-000061 001-40693 25924025 34 5240506 1 1
2025-05-08 8-K 8-K 2.02,9.01 0001739410-25-000059 001-40693 25924012 34 231071 1 1
2025-04-08 8-K 8-K 8.01,9.01 0001739410-25-000052 001-40693 25820367 34 188660 1 1
2025-04-07 DEF 14A DEF 14A 0001739410-25-000045 001-40693 25818696 34 765523
2025-03-13 8-K 8-K 8.01,9.01 0001739410-25-000041 001-40693 25736524 34 207335 1 1
2025-03-13 424B5 424B5 0001193125-25-053960 333-266668 25736342 33 271739
2025-03-13 10-K 10-K 0001739410-25-000040 001-40693 25735745 34 9260439 1 1
2025-03-13 8-K 8-K 2.02,9.01 0001739410-25-000029 001-40693 25733899 34 255039 1 1
2025-02-25 8-K 8-K 3.01 0001739410-25-000021 001-40693 25664172 34 156878 1 1
2025-02-19 4 FORM 4 0001739410-25-000014 5429
2025-02-19 4 FORM 4 0001739410-25-000013 5436
2025-02-19 4 FORM 4 0001739410-25-000012 5482
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000886 005-92742 25612584 34 11330
2025-01-06 4 FORM 4 0001739410-25-000008 5614
2025-01-06 4 FORM 4 0001739410-25-000007 5612
2025-01-06 4 FORM 4 0001739410-25-000006 5636
2025-01-06 4 FORM 4 0001739410-25-000005 5577
2024-11-12 SC 13G/A filing.txt 0000315066-24-002857 005-92742 241444935 34 7828
2024-11-07 10-Q 10-Q 0001739410-24-000136 001-40693 241435657 34 5341619 1 1
2024-11-07 8-K 8-K 2.02,9.01 0001739410-24-000132 001-40693 241433311 34 264098 1 1
2024-09-17 8-K 8-K 5.02 0001739410-24-000121 001-40693 241302639 34 153569 1 1
2024-08-08 10-Q 10-Q 0001739410-24-000115 001-40693 241186181 34 6029939 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001739410-24-000114 001-40693 241186164 34 257218 1 1
2024-07-30 SC 13G rallybiosch13gforjjdc.htm 0000904454-24-000439 005-92742 241159603 34 48866
2024-07-30 SC 13G/A SC 13G/A 0001193125-24-188672 005-92742 241156077 34 64549
2024-07-23 8-K 8-K 5.02,9.01 0001739410-24-000105 001-40693 241134522 34 208293 1 1
2024-05-21 8-K 8-K 5.07 0001739410-24-000098 001-40693 24969673 34 162010 1 1
2024-05-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-20 16:00:00 9999999995-24-001593 333-279317 24966728 33 1840
2024-05-17 4 FORM 4 0001739410-24-000094 5433
2024-05-17 4 FORM 4 0001739410-24-000093 5421
2024-05-17 4 FORM 4 0001739410-24-000092 5398
2024-05-17 4 FORM 4 0001739410-24-000091 5426
2024-05-17 4 FORM 4 0001739410-24-000090 5395
2024-05-17 4 FORM 4 0001739410-24-000089 5444
2024-05-17 4 FORM 4 0001739410-24-000088 5457
2024-05-17 4 FORM 4 0001739410-24-000087 5412
2024-05-16 CORRESP filename1.htm 0001193125-24-140422 6982
2024-05-16 UPLOAD filename1.pdf 0000000000-24-005640 333-279317 40363
2024-05-10 S-3 S-3 0001193125-24-136133 333-279317 24934662 33 481654
2024-05-09 10-Q 10-Q 0001739410-24-000057 001-40693 24930609 34 4636197 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001739410-24-000053 001-40693 24928709 34 231927 1 1
2024-04-22 D xslFormDX01/primary_doc.xml 06b 0001739410-24-000047 021-511203 24860890 33 15596
2024-04-11 DEF 14A DEF 14A 0001739410-24-000045 001-40693 24838594 34 793261
2024-04-10 8-K 8-K 1.01,3.02,7.01,9.01 0001739410-24-000040 001-40693 24835880 34 203448 1 1
2024-03-13 S-8 S-8 0001193125-24-066873 333-277880 24746446 33 57434
2024-03-12 10-K 10-K 0001739410-24-000035 001-40693 24742457 34 8361550 1 1
2024-03-12 8-K 8-K 2.02,9.01 0001739410-24-000030 001-40693 24740262 34 257875 1 1
2024-02-16 4 FORM 4 0001739410-24-000020 5403
2024-02-16 4 FORM 4 0001739410-24-000019 5443
2024-02-16 4 FORM 4 0001739410-24-000018 5447
2024-02-16 4 FORM 4 0001739410-24-000017 5409
2024-02-14 SC 13G/A sayw24021417_13ga.htm 0000905148-24-000620 005-92742 24633619 34 288570
2024-02-12 SC 13D/A SC 13D/A 0001193125-24-032553 005-92742 24622298 34 141001
2024-02-09 SC 13G/A filing.txt 0000315066-24-001447 005-92742 24612083 34 7797
2024-02-06 8-K 8-K 2.02,2.05,9.01 0001739410-24-000012 001-40693 24598151 34 195916 1 1
2024-01-04 4 FORM 4 0001739410-24-000004 5570
2024-01-04 4 FORM 4 0001739410-24-000003 5581
2024-01-02 SC 13G/A SC 13G/A 0001193125-24-000710 005-92742 24502863 34 43575
2023-12-20 8-K 8-K 7.01,9.01 0001739410-23-000019 001-40693 231499418 34 3176700 1 1
2023-11-09 10-Q 10-Q 0001739410-23-000014 001-40693 231392467 34 4469590 1 1
2023-11-09 8-K 8-K 2.02,9.01 0001739410-23-000011 001-40693 231390176 34 250372 1 1
2023-08-08 10-Q 10-Q 0001739410-23-000007 001-40693 231151631 34 16823567 1 1
2023-08-08 8-K 8-K 2.02,9.01 0001739410-23-000004 001-40693 231149458 34 250460 1 1
2023-06-29 8-K 8-K 5.02,9.01 0000950170-23-030535 001-40693 231054312 34 268364 1 1
2023-05-22 8-K 8-K 5.07 0000950170-23-023468 001-40693 23944938 34 199181 1 1
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013407 5427
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013406 5445
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013405 5422
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013404 5458
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013402 5396
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013398 5399
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013396 5434
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013393 5413
2023-05-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-12 16:00:00 9999999995-23-001418 333-271748 23918043 33 1760
2023-05-12 424B3 424B3 0001193125-23-143580 333-271748 23916670 33 144037
2023-05-11 CORRESP filename1.htm 0001193125-23-141890 7431
2023-05-11 UPLOAD filename1.pdf 0000000000-23-004995 40214
2023-05-10 S-8 S-8 0001193125-23-140753 333-271805 23906722 33 63242
2023-05-09 S-3 S-3 0001193125-23-138977 333-271748 23900171 33 252569
2023-05-09 10-Q 10-Q 0000950170-23-019165 001-40693 23900099 34 6737979 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019161 001-40693 23900082 34 354852 1 1
2023-04-10 DEF 14A DEF 14A 0000950170-23-012313 001-40693 23811759 34 1381309
2023-03-16 4 4 0000950170-23-008553 5048
2023-03-09 4 FORM 4 SUBMISSION 0001209191-23-017538 6484
2023-03-09 4 FORM 4 SUBMISSION 0001209191-23-017533 11715
2023-03-06 10-K 10-K 0000950170-23-006264 001-40693 23709350 34 15300398 1 1
2023-03-06 8-K 8-K 2.02,7.01,9.01 0000950170-23-006125 001-40693 23707663 34 537928 1 1
2023-02-09 SC 13G/A filing.txt 0000315066-23-001356 005-92742 23601212 34 7715
2023-02-06 4 FORM 4 SUBMISSION 0000899243-23-004078 5439
2023-02-06 4 FORM 4 SUBMISSION 0000899243-23-004077 5408
2023-02-06 4 FORM 4 SUBMISSION 0000899243-23-004074 5451
2023-02-06 SC 13G/A SC 13G/A 0001193125-23-025652 005-92742 23591137 34 144343
2023-02-01 4 FORM 4 SUBMISSION 0000899243-23-003156 5512
2023-02-01 3 FORM 3 SUBMISSION 0000899243-23-003154 7097
2023-02-01 SC 13G/A SC 13G/A 0001193125-23-021617 005-92742 23577229 34 63400
2023-01-31 8-K 8-K 5.02,9.01 0000950170-23-001474 001-40693 23572764 34 241192 1 1
2023-01-23 SC 13G/A SC 13G/A 0001104659-23-005733 005-92742 23543478 34 56342
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001049 5322
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001048 5354
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001046 5333
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001044 5361
2022-12-01 8-K 8-K 8.01,9.01 0001193125-22-295957 001-40693 221437424 34 174690 1 1
2022-11-17 4 xslF345X03/form4.xml 0001140361-22-042081 18728
2022-11-17 SC 13G SC 13G 0001193125-22-287471 005-92742 221397535 34 41264
2022-11-14 8-K 8-K 1.01,8.01,9.01 0001193125-22-284569 001-40693 221385383 34 688948 1 1
2022-11-14 424B5 424B5 0001193125-22-283756 333-266668 221380447 33 399409
2022-11-10 424B5 424B5 0001193125-22-282070 333-266668 221375308 33 406148
2022-11-07 10-Q 10-Q 0000950170-22-022342 001-40693 221363859 34 8181168 1 1
2022-11-07 8-K 8-K 2.02,9.01 0000950170-22-022335 001-40693 221363788 34 441255 1 1
2022-09-28 8-K 8-K 7.01,9.01 0000950170-22-018936 001-40693 221272836 34 230519 1 1
2022-08-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-08-15 16:00:00 9999999995-22-002385 333-266668 221168339 33 1761
2022-08-15 424B5 424B5 0001193125-22-221342 333-266668 221167138 33 245581
2022-08-11 CORRESP filename1.htm 0001193125-22-218532 6266
2022-08-11 UPLOAD filename1.pdf 0000000000-22-008535 40199
2022-08-08 S-3 S-3 0001193125-22-215079 333-266668 221145550 33 583756
2022-08-08 10-Q 10-Q 0000950170-22-015571 001-40693 221144896 34 8029308 1 1
2022-08-08 8-K 8-K 2.02,9.01 0000950170-22-015259 001-40693 221142684 34 426208 1 1
2022-08-03 4 FORM 4 SUBMISSION 0000899243-22-027631 5343
2022-08-03 3 FORM 3 SUBMISSION 0000899243-22-027628 7042
2022-08-02 8-K 8-K 5.02,7.01,9.01 0000950170-22-013744 001-40693 221126963 34 217935 1 1
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034860 7462
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034858 15919
2022-06-07 SC 13D/A SC 13D/A 0001104659-22-068929 005-92742 221001212 34 149715
2022-06-06 S-8 S-8 0001193125-22-168379 333-265443 22998471 33 63925
2022-06-02 8-K 8-K 5.02,9.01 0000950170-22-011050 001-40693 22989347 34 210512 1 1
2022-05-27 8-K 8-K 5.07 0000950170-22-010851 001-40693 22977184 34 193814 1 1
2022-05-26 4 FORM 4 SUBMISSION 0000899243-22-019835 5365
2022-05-26 4 FORM 4 SUBMISSION 0000899243-22-019834 5365
2022-05-26 4 FORM 4 SUBMISSION 0000899243-22-019832 5403
2022-05-26 4 FORM 4 SUBMISSION 0000899243-22-019830 5391
2022-05-26 4 FORM 4 SUBMISSION 0000899243-22-019829 5427
2022-05-26 4 FORM 4 SUBMISSION 0000899243-22-019828 5410
2022-05-26 4 FORM 4 SUBMISSION 0000899243-22-019827 5415
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031969 7461
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031966 15913
2022-05-10 10-Q 10-Q 0000950170-22-009013 001-40693 22910270 34 6473061 1 1
2022-05-10 8-K 8-K 1.01,2.02,8.01,9.01 0000950170-22-008944 001-40693 22909412 34 379395 1 1
2022-04-25 DEF 14A DEF 14A 0000950170-22-006110 001-40693 22850484 34 1137116
2022-04-06 4 FORM 4 SUBMISSION 0000899243-22-014169 5377
2022-04-06 4 FORM 4 SUBMISSION 0000899243-22-014167 5331
2022-04-06 3 FORM 3 SUBMISSION 0000899243-22-014165 7219
2022-04-06 3 FORM 3 SUBMISSION 0000899243-22-014163 7286
2022-04-04 8-K 8-K 5.02,7.01,9.01 0000950170-22-005307 001-40693 22800458 34 216318 1 1
2022-03-23 4 FORM 4 SUBMISSION 0000899243-22-011950 8135
2022-03-15 10-K 10-K 0000950170-22-003767 001-40693 22741578 34 11441876 1 1
2022-03-15 8-K 8-K 2.02,9.01 0000950170-22-003666 001-40693 22739220 34 375639 1 1
2022-03-07 8-K 8-K 7.01,9.01 0000950170-22-002960 001-40693 22716306 34 3022208 1 1
2022-02-14 SC 13G/A SC 13G/A 0001140361-22-005364 005-92742 22634233 34 283674
2022-02-11 SC 13G SC 13G 0001193125-22-037232 005-92742 22621982 34 164365
2022-02-10 4 FORM 4 SUBMISSION 0001209191-22-008584 15886
2022-02-10 4 FORM 4 SUBMISSION 0001209191-22-008579 7456
2022-02-09 4 FORM 4 SUBMISSION 0000899243-22-005526 5414
2022-02-09 4 FORM 4 SUBMISSION 0000899243-22-005521 5437
2022-02-09 4 FORM 4 SUBMISSION 0000899243-22-005519 5445
2022-02-09 4 FORM 4 SUBMISSION 0000899243-22-005518 5406
2022-02-08 SC 13G SC 13G 0001193125-22-030786 005-92742 22600359 34 80313
2022-01-21 4 FORM 4 SUBMISSION 0000899243-22-002911 8126
2022-01-21 SC 13G SC 13G 0001104659-22-006354 005-92742 22544928 34 56345
2022-01-18 SC 13D/A AMENDED SCHEDULE 13D 0001387131-22-000436 005-92742 22536059 34 129100
2022-01-14 4 FORM 4 SUBMISSION 0000899243-22-002043 22481
2022-01-12 4 FORM 4 SUBMISSION 0000899243-22-001801 25572
2022-01-11 4 FORM 4 SUBMISSION 0000899243-22-001629 34724
2022-01-05 4 FORM 4 SUBMISSION 0000899243-22-001062 5382
2022-01-05 4 FORM 4 SUBMISSION 0000899243-22-001060 5358
2022-01-05 4 FORM 4 SUBMISSION 0000899243-22-001058 5371
2022-01-05 4 FORM 4 SUBMISSION 0000899243-22-001057 5357
2022-01-05 4 FORM 4 SUBMISSION 0000899243-22-001056 5320
2021-11-10 10-Q 10-Q 0000950170-21-004125 001-40693 211397249 34 5314588 1 1
2021-11-10 8-K 8-K 2.02,9.01 0000950170-21-003919 001-40693 211394417 34 450801 1 1
2021-09-09 10-Q 10-Q 0000950170-21-001740 001-40693 211244592 34 5996954 1 1
2021-09-09 8-K 8-K 2.02,9.01 0000950170-21-001739 001-40693 211244535 34 375653 1 1
2021-08-12 SC 13D SCHEDULE 13D 0001387131-21-008423 005-92742 211168548 34 82252
2021-08-12 SC 13D SC 13D 0001193125-21-244841 005-92742 211168495 34 171654
2021-08-12 SC 13D SC 13D 0001104659-21-104153 005-92742 211167565 34 242558
2021-08-09 SC 13G SCHEDULE 13G 0001387131-21-008259 005-92742 211156506 34 119371
2021-08-04 4 FORM 4 SUBMISSION 0001209191-21-049823 22308
2021-08-04 4 FORM 4 SUBMISSION 0001209191-21-049821 14935
2021-08-04 3/A FORM 3/A SUBMISSION 0001209191-21-049819 14550
2021-08-04 4 FORM 4 SUBMISSION 0000899243-21-031635 12821
2021-08-04 4 FORM 4 SUBMISSION 0000899243-21-031634 20135
2021-08-04 4 FORM 4 SUBMISSION 0000899243-21-031633 17863
2021-08-04 SC 13G filing.txt 0000315066-21-001651 005-92742 211143747 34 8185
2021-08-04 4 PRIMARY DOCUMENT 0000315066-21-001650 9312
2021-08-02 4 xslF345X03/ownership.xml 0001387131-21-007995 21911
2021-08-02 S-8 S-8 0001193125-21-233473 333-258383 211136980 33 73596
2021-08-02 8-K 8-K 1.01,3.03,5.03,9.01 0001193125-21-233263 001-40693 211136231 34 261694
2021-07-30 424B4 424B4 0001193125-21-230254 333-257655 211130194 33 4140049
2021-07-29 3 xslF345X02/ownership.xml 0001387131-21-007921 15636
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048711 14161
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030703 8929
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030702 10926
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030701 8508
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030700 9007
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030695 9019
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030696 9921
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030693 9756
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030692 9755
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030690 10148
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030689 9006
2021-07-29 3 FORM 3 SUBMISSION 0000899243-21-030685 11964
2021-07-29 3 PRIMARY DOCUMENT 0000315066-21-001643 6614
2021-07-29 CERT 8A_Cert_RLYB.pdf 0001354457-21-000871 001-40693 211124961 34 748574
2021-07-29 8-A12B 8-A12B 0001193125-21-228072 001-40693 211124668 34 14742
2021-07-28 SEC STAFF LETTER filename1.pdf 9999999997-21-004408 271673
2021-07-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-07-28 16:00:00 9999999995-21-002956 333-257655 211124620 33 1761
2021-07-28 S-1MEF S-1MEF 0001193125-21-227780 333-258244 211124444 33 55118
2021-07-26 CORRESP filename1.htm 0001193125-21-224490 10450
2021-07-26 CORRESP filename1.htm 0001193125-21-224489 6771
2021-07-22 S-1/A S-1/A #1 0001193125-21-221832 333-257655 211107634 33 6024978
2021-07-12 CORRESP filename1.htm 0001193125-21-212796 61781
2021-07-02 S-1 S-1 0001193125-21-207662 333-257655 211070544 33 5174047
2021-06-07 DRSLTR filename1.htm 0000950123-21-007614 31050
2021-06-07 DRS/A filename1.htm 0000950123-21-007613 377-04734 211000421 33 3869653
2021-05-24 UPLOAD filename1.pdf 0000000000-21-006487 49272
2021-05-13 SEC STAFF LETTER filename1.pdf 9999999997-21-002686 272545
2021-04-27 DRS filename1.htm 0000950123-21-004979 377-04734 21860075 33 4064568
2020-05-29 D/A xslFormDX01/primary_doc.xml 06b 0001739410-20-000002 021-364823 20923660 33 12898
2020-04-13 D xslFormDX01/primary_doc.xml 06b 0001739410-20-000001 021-364823 20788578 33 12014
2018-05-07 D xslFormDX01/primary_doc.xml 06b 0001739410-18-000001 021-311753 18809954 33 7947

Latest XBRL company facts

One latest value per concept from companyfacts (227 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 5.38M 2026-10-20 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
dei EntityPublicFloat Entity Public Float USD 10.60M 2025-06-30 2025 FY 10-K 2026-03-16 0001628280-26-018261
ffd NetFeeAmt NetFeeAmt USD 0.08 2026-08-26 S-4/A 2026-08-26 0001193125-26-368568
ffd TtlFeeAmt TtlFeeAmt USD 0.99 2026-08-26 S-4/A 2026-08-26 0001193125-26-368568
ffd TtlOfferingAmt TtlOfferingAmt USD 7,092.7 2026-08-26 S-4/A 2026-08-26 0001193125-26-368568
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-26 S-4/A 2026-08-26 0001193125-26-368568
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0.91 2026-08-26 S-4/A 2026-08-26 0001193125-26-368568
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 7,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 1.17M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 1.35M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.47M 2026-06-30 S-4/A 2026-08-26 0001193125-26-368568
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 364,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 480,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 361.63M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 3.20M 2021-08-01 2021-08-31 2021 FY 10-K 2022-03-15 0000950170-22-003767
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 2.12M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004125
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 268,000 2024-01-01 2024-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -56,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 160.31M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap Assets Assets USD 95.58M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AssetsCurrent Assets, Current USD 94.77M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 88.04M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 88.04M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 88.04M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 88.04M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001739410-24-000136
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 90.69M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 90.70M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 90.69M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 51.71M 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022342
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -17.44M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019165
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 59.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 137.92M 2020-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 5.33M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 5.33M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap CommonUnitAuthorized Common Unit, Authorized shares 165.39M 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap CommonUnitIssued Common Unit, Issued shares 4.50M 2018-12-31 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 32.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003767
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003767
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0001739410-23-000014
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions investment 0 2025-09-30 2025 Q3 10-Q 2025-11-06 0001739410-25-000132
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0001739410-25-000040
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 100.45M 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 25.70M 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 50.32M 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 183.30M 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 181.60M 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 301,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.40M 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 100.45M 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap Depreciation Depreciation USD 100,000 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 5.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.48 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009013
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 5.64 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.245 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.137 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.054 2024-01-01 2024-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesOther Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001628280-26-018261
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.107 2024-01-01 2024-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.026 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022342
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 13.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -8.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001628280-26-018261
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -8.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001628280-26-018261
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001628280-26-018261
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 34.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0001739410-25-000040
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0001739410-25-000040
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.20M 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.89M 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncomeTaxReconciliationNondeductibleExpenseAmortization Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount USD 2.31M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.23M 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 17,000 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003767
us-gaap IncomeTaxReconciliationTaxContingenciesOther Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount USD 17,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001628280-26-018261
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 231,000 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.23M 2026-01-01 2026-06-30 S-4/A 2026-08-26 0001193125-26-368568
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -212,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap InterestAndOtherIncome Interest and Other Income USD 1.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap InterestExpense Interest Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 626,000 2025-06-30 2025 Q2 10-Q 2025-08-07 0001739410-25-000112
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 190,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2021-12-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009013
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 106,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 156,000 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022342
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 0 2023-12-31 2023 FY 10-K 2024-03-12 0001739410-24-000035
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 84,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 14,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap Liabilities Liabilities USD 3.28M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 95.58M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.28M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap MembersEquity Members' Equity USD -69.36M 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 254,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 23.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 35.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 32.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -24.40M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap NetRentableArea Net Rentable Area sqft 4,500 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003767
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 51.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OperatingExpenses Operating Expenses USD 18.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -17.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 176,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 170,000 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 176,000 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 230,000 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 195,000 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 30,000 2026-06-30 S-4/A 2026-08-26 0001193125-26-368568
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.46M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 300,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 810,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 390,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 678,000 2026-01-01 2026-06-30 S-4/A 2026-08-26 0001193125-26-368568
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 762,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap OtherReceivablesGrossCurrent Other Receivables, Gross, Current USD 1.00M 2026-06-30 S-4/A 2026-08-26 0001193125-26-368568
us-gaap PaymentsForRent Payments for Rent USD 133,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003767
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 300,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022342
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 100,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-08 0000950170-22-015571
us-gaap PaymentsToAcquireInterestInJointVenture Payments to Acquire Interest in Joint Venture USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0001739410-25-000040
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.08M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap PrepaidInsurance Prepaid Insurance USD 593,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ProceedsFromDivestitureOfInterestInJointVenture Proceeds from Divestiture of Interest in Joint Venture USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 0 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 23.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 241,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 16,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001628280-26-018261
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -32.08M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-08 0000950170-22-015571
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 503,000 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 3.30M 2024-03-31 2024 Q3 10-Q 2024-11-07 0001739410-24-000136
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 1.70M 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.4 2025-05-02 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap RestructuringReserve Restructuring Reserve USD 837,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -269.34M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap Revenues Revenues USD 212,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 700,000 2022-01-01 2022 Q3 10-Q 2022-11-07 0000950170-22-022342
us-gaap SeveranceCosts1 Severance Costs USD 2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001628280-26-034580
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.36M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 456,886 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 52.1 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 13,317 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 11,404 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 32,360 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.44M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 597,621 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 43.1 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.38M 2018-12-31 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 200,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003767
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022342
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 93.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 15.7 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap SharePrice Share Price USD/shares 17.2 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 2.085 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 92.30M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 169.32M 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006264
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 38,298 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 50.00M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 5.14M 2024-01-01 2024-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 21,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0001739410-24-000035
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2024-01-01 2024-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 84,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-09 0000950170-21-001740
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 241,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001628280-26-018261
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.50M 2025-01-01 2025-12-31 S-4/A 2026-08-26 0001193125-26-368568
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 5.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 30.32M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009013
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 5.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001628280-26-067422

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →